Dark

AYTU
AYTU BioPharma, Inc. Common Stock
stock NASDAQ

At Close

May 9, 2025

1.25USD+3.050%(+0.04)18,321

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 7, 2025 8:39:30 AM EDT

1.20USD-1.072%(-0.01)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 4, 2022

08:10AM EST Aytu BioPharma Appoints Mark Oki As Chief Financial Officer Benzinga

Dec 22, 2021

12:07PM EST Aytu Biosciences National Institutes Of Health ClinicalTrials.gov Listing For Co.'s 'Respiratory COVID-19: A Randomized, Sham-Controlled Study,' Shows Now Recruiting Benzinga

Dec 14, 2021

09:30AM EST and Orphan Drug Designation for Enzastaurin in Vascular Ehlers-Danlos Syndrome PR Newswire

Dec 13, 2021

08:08AM EST Aytu BioPharma Announces FDA Clearance Of Investigational New Drug Application For AR101/Enzastaurin In Vascular Ehlers-Danlos Syndrome Benzinga

Dec 8, 2021

08:04AM EST Aytu Biopharma Reports Receives Orphan Drug Designation From FDA For AR101 For Treatment Of Vascular Ehlers-Danlos Syndrome; BZ NOTE: Benzinga Reported On This Information Via The FDA Website On Tuesday Benzinga

Nov 23, 2021

08:04AM EST Aytu BioPharma Announces Issuance Of First US Patent Supporting Healight Ultraviolet-A Respiratory Catheter Benzinga

Nov 15, 2021

05:02PM EST UPDATE: AYTU Q1 Adj. EPS $(0.33) Benzinga

04:18PM EST Aytu BioScience Q1 EPS $(1.09) Down From $(0.35) YoY, Sales $21.90M Miss $22.10M Estimate Benzinga

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

10:37AM EST The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More Benzinga

Oct 12, 2021

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Sep 30, 2021

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 29, 2021

07:05AM EDT Recap: Aytu BioPharma Q4 Earnings Benzinga

Sep 27, 2021

04:10PM EDT Aytu BioScience Q4 Sales $23.50M Beat $20.90M Estimate Benzinga

05:01AM EDT Earnings Scheduled For September 27, 2021 Benzinga

Sep 22, 2021

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 21, 2021

08:20AM EDT The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data Benzinga

Sep 17, 2021

07:36AM EDT The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold Benzinga

Sep 15, 2021

07:38AM EDT The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs Benzinga

Sep 14, 2021

07:50AM EDT The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout Benzinga

Sep 9, 2021

08:11AM EDT Aytu BioPharma Announces Formation Of New Scientific Advisory Board To Support Development Of AR101 For Vascular Ehlers-Danlos Syndrome Benzinga

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Aug 13, 2021

07:43AM EDT The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO Benzinga

Aug 6, 2021

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 5, 2021

08:08AM EDT The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO Benzinga

Aug 4, 2021

07:52AM EDT The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings Benzinga

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 27, 2021

11:13AM EDT Aytu BioPharma Highlights Publication Of Data From A Study Evaluating Ultraviolet-A Light Used In Healight In The Journal 'Photodiagnosis and Photodynamics Therapy' Benzinga

11:13AM EDT The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts Benzinga

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jul 15, 2021

08:08AM EDT The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs Benzinga

Jul 9, 2021

07:36AM EDT The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO Benzinga

Jul 8, 2021

07:45AM EDT The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test Benzinga

Jun 28, 2021

08:55AM EDT Aytu BioPharma Announces Peer-Reviewed Publication Of Clinical Results From Healight(TM) Pilot Study Benzinga

May 26, 2021

07:33AM EDT The Daily Biotech Pulse: Nabriva Jumps On Data, Larimar Wilts After Study Put On Hold, Travere To Delay Regulatory Filing Benzinga

May 20, 2021

06:12AM EDT Aytu Biopharma Inc Delivered Written Notice To Jefferies To Terminate Sales Agreement Dated June 5, 2020 Effective June 2, 2021; Not Subject To Any Termination Penalties Related To Termination Of Sales Agreement Benzinga

May 18, 2021

07:44AM EDT The Daily Biotech Pulse: Spero Secures NIAID Funding, GlaxoSmithKline Releases COVID-19 Data, BioNTech Gets New CFO Benzinga

May 17, 2021

04:48PM EDT Recap: Aytu BioPharma Q3 Earnings Benzinga

04:34PM EDT Aytu BioScience Q3 EPS $(0.43) Misses $(0.31) Estimate, Sales $13.48M Miss $14.06M Estimate Benzinga

04:10AM EDT Earnings Scheduled For May 17, 2021 Benzinga

May 12, 2021

10:52AM EDT Aytu BioPharma Announces Publication Of In Vitro Study, Says Demonstrates That Ultraviolet-A Light Increases Mitochondrial Anti-Viral Signaling Protein Within Cells Benzinga

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

Apr 12, 2021

08:10AM EDT Aytu BioPharma Acquires Global License To AR101 For Ehlers-Danlos Syndrome For $1.5M Upfront Cash Payment, Will Pau Up To $22.5M In Milestones Upon Regulatory Milestones And Additional $45M In Commercial Milestones Benzinga

Apr 5, 2021

08:05AM EDT Aytu BioPharma Announces Richard Eisenstadt CFO, Previous CFO Stepped Down Effective March 31st, 2021 Benzinga

Apr 1, 2021

07:33AM EDT Aytu BioPharma Divests US Rights To Natesto To Acerus Pharma; Co. To Receive $7.5M In Cash, Payable Over 30 Monthly $250K Payments Benzinga

Mar 30, 2021

10:08AM EDT Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2021 Benzinga

06:28AM EDT Cantor Fitzgerald Initiates Coverage On Aytu BioPharma with Overweight Rating, Announces Price Target of $11 Benzinga

Mar 19, 2021

07:46AM EDT The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs Benzinga

Mar 18, 2021

06:22AM EDT Why Are Neos Therapeutics, Aytu BioScience Stocks Soaring Today? Benzinga

Mar 11, 2021

03:06PM EST 'Keep an eye out for a big announcement coming soon. We're excited to be making some changes while staying focused on good health for people of all ages and all walks of life.' -Tweet from Co. Benzinga

Mar 9, 2021

09:17AM EST The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data Benzinga

06:11AM EST Aytu BioScience Stock Is Trading Higher After Healight Therapy Shows Improved Outcome In COVID-19 Patients Benzinga

Mar 8, 2021

06:28PM EST Shares of Aytu BioScience, Inc. (AYTU) jumped over 10% in extended trading Monday after the company announced positive clinical results from healight pilot study in COVID-19 patients. RTTNews

04:02PM EST Aytu BioScience Announces Clinical Results From Healight Pilot Study In SARS-CoV-2; Says 'Data indicate endotracheal UVA light catheter therapy reduces SARS-CoV-2 viral load and improves clinical outcomes in mechanically ventilated SARS-CoV-2 patients' Benzinga

Feb 11, 2021

04:09PM EST Aytu BioScience Q2 Sales $15.15M Beat $12.25M Estimate Benzinga

03:51AM EST Earnings Scheduled For February 11, 2021 Benzinga

Feb 10, 2021

08:05AM EST Aytu BioScience And Neos Therapeutics Announce Special Meetings Of Stockholders Related To Proposed Merger To Be Held On March 18, 2021 Benzinga

08:00AM EST Record date for each Special Meeting of Stockholders is February 5, 2021 GlobeNewswire Inc

Feb 6, 2021

12:42PM EST The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight Benzinga

Jan 25, 2021

04:15PM EST UPDATE: Aytu Will 'license the intellectual property surrounding the use and commercialization of their rapid in vitro diagnostic semen analysis test that accurately measures oxidative stress, including all components of the MiOXSYS commercial system' Benzinga

04:14PM EST Aytu BioScience Signs Exclusive License Agreement With Avrio Genetics Benzinga

Dec 28, 2020

08:06AM EST Aytu BioSicence Reports Completion Of Healight Safety Study In COVID-19 Patients Benzinga

Dec 24, 2020

10:49PM EST Lifshitz Law Firm, P.C. Announces Investigation of AJRD, CATM, EXPC, GNBF, PR Newswire

Dec 21, 2020

05:20PM EST Armistice Capital Reports In 13D Filing A 7.7% Stake In AYTU Biosciences Benzinga

Dec 16, 2020

09:20PM EST Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Neos Therapeutics, Inc. - NEOS PR Newswire

05:56AM EST Aytu Bioscience Director Steven Boyd Reported Purchase of 1,333,334 Shares @ Avg Price of $6.00/Share in Form 4 Filing on Tuesday Benzinga

Dec 11, 2020

11:41AM EST Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Neos Therapeutics, Inc. (NASDAQ: NEOS) breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by Aytu BioScience, Inc. (NASDAQ: AYTU). GlobeNewswire Inc

10:39AM EST SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation GlobeNewswire Inc

08:11AM EST The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street Benzinga

Dec 10, 2020

07:35PM EST ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Neos PR Newswire

04:52PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates Neos Therapeutics, Inc. PR Newswire

10:12AM EST Mid-Morning Market Update: Markets Mixed; Adobe Earnings Top Views Benzinga

08:28AM EST Aytu BioScience, Neos Therapeutics Enter Definitive Merger Agreement RTTNews

08:00AM EST -- Merger accelerates transformation to profitability, with estimated annualized cost synergies of $15MbeginningFY 2022 GlobeNewswire Inc

07:01AM EST Aytu BioScience And Neos Therapeutics Earlier Announced Definitive Merger Agreement Valued At ~$44.9M; Neos Stockholders Will Be Entitled To Receive 0.1088 Shares Of Common Stock Of Aytu For Each Share Of Neos Common Stock Held Benzinga

Dec 9, 2020

10:30AM EST Looking Into Aytu BioScience's Return On Capital Employed Benzinga

Nov 12, 2020

04:03PM EST Aytu BioScience Q1 EPS $(0.04) Beats $(0.05) Estimate, Sales $13.50M Beat $13.33M Estimate Benzinga

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

04:18AM EST Earnings Scheduled For November 12, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Oct 7, 2020

02:33PM EDT Mid-Afternoon Market Update: Dow Surges 500 Points; CleanSpark Shares Plummet Benzinga

12:18PM EDT Mid-Day Market Update: Gold Falls 1%; Sunworks Shares Spike Higher Benzinga

Oct 6, 2020

05:37PM EDT Recap: Aytu BioScience Q4 Earnings Benzinga

04:03PM EDT Aytu BioScience Q4 EPS $(0.03), Inline, Sales $14.90M Beat $11.24M Estimate Benzinga

04:06AM EDT Earnings Scheduled For October 6, 2020 Benzinga

Oct 5, 2020

10:05AM EDT Preview: Aytu BioScience's Earnings Benzinga

Sep 24, 2020

04:01AM EDT Earnings Scheduled For September 24, 2020 Benzinga

Sep 23, 2020

10:26AM EDT Aytu BioScience's Earnings Outlook Benzinga

Sep 8, 2020

08:03AM EDT Aytu BioScience Announces Global Agreement To Distribute Pinnacle IVD Corporation's 15-Minute COVID-19 Antigen Test Benzinga

Aug 19, 2020

10:41AM EDT Aytu BioScience shares are trading higher after the company announced the launch of its nationwide mobile coronavirus testing initiative. Benzinga

08:10AM EDT Aytu BioScience Announces Launch of Nationwide Mobile Coronavirus Testing Initiative Benzinga

Aug 17, 2020

08:03AM EDT Aytu BioScience Announces its Healight Devices Were Manufactured Enabling the Company to Begin a Clinical Study for COVID-19 Benzinga

Jul 20, 2020

07:36AM EDT Aytu BioScience Announces Expansion Of NATESTO US Commercial Team Benzinga

Jul 16, 2020

03:19PM EDT Aytu BioScience Signs Development Agreement With Sterling Medical Devices To Advance The Development Of Healight As A Potential Coronavirus Treatment BZ NOTE: This PR Is Dated April 27, But Traders Circulated It Today Benzinga

02:55PM EDT Aytu BioScience Signs Development Agreement With Sterling Medical Devices To Advance The Development Of Healight As A Potential Coronavirus Treatment Benzinga